On Invalid Date, Enveric Biosciences (NASDAQ: ENVB) reported Q4 2023 earnings per share (EPS) of -$1.47, up 69.94% year over year. Total Enveric Biosciences earnings for the quarter were -$3.44 million. In the same quarter last year, Enveric Biosciences's earnings per share (EPS) was -$4.89.
As of Q2 2024, Enveric Biosciences's earnings has grown year over year. Enveric Biosciences's earnings in the past year totalled -$17.46 million.
What is ENVB's earnings date?
Enveric Biosciences's earnings date is Invalid Date. Add ENVB to your watchlist to be reminded of ENVB's next earnings announcement.
What was ENVB's revenue last quarter?
On Invalid Date, Enveric Biosciences (NASDAQ: ENVB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Enveric Biosciences's revenue was $0.00.
What was ENVB's revenue growth in the past year?
As of Q2 2024, Enveric Biosciences's revenue has grown null year over year. Enveric Biosciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.